Literature DB >> 10586052

Distinct activities of p52/NF-kappa B required for proper secondary lymphoid organ microarchitecture: functions enhanced by Bcl-3.

L Poljak1, L Carlson, K Cunningham, M H Kosco-Vilbois, U Siebenlist.   

Abstract

Mice rendered deficient in p52, a subunit of NF-kappa B, or in Bcl-3, an I kappa B-related regulator that associates with p52 homodimers, share defects in the microarchitecture of secondary lymphoid organs. The mutant mice are impaired in formation of B cell follicles and are unable to form proper follicular dendritic cell (FDC) networks upon antigenic challenge. The defects in formation of B cell follicles may be attributed, at least in part, to impaired production of the B lymphocyte chemoattractant (BLC) chemokine, possibly a result of defective FDCs. The p52- and Bcl-3-deficient mice exhibit additional defects within the splenic marginal zone, including reduced numbers of metallophilic macrophages, reduced deposition of the laminin-beta 2 chain and impaired expression of a mucosal addressin marker on sinus-lining cells. Whereas p52-deficient mice are severely defective in all of these aspects, Bcl-3-deficient mice are only partially defective. We determined that FDCs or other non-hemopoietic cells that underlie FDCs are intrinsically impaired in p52-deficient mice. Adoptive transfers of wild-type bone marrow into p52-deficient mice failed to restore FDC networks or follicles. The transfers did restore metallophilic macrophages to the marginal zone, however. Together, the results suggest that p52 carries out functions essential for a proper splenic microarchitecture in both hemopoietic and non-hemopoietic cells and that Bcl-3 is important in enhancing these essential activities of p52.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10586052

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

Review 2.  NF-kappaB pathways in the immune system: control of the germinal center reaction.

Authors:  Christine A Goetz; Albert S Baldwin
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  A role for the IkappaB family member Bcl-3 in the control of central immunologic tolerance.

Authors:  Xiaoren Zhang; Hongshan Wang; Estefania Claudio; Keith Brown; Ulrich Siebenlist
Journal:  Immunity       Date:  2007-09       Impact factor: 31.745

4.  Role of CCL19/21 and its possible signaling through CXCR3 in development of metallophilic macrophages in the mouse thymus.

Authors:  Novica M Milićević; Miloš D Miljković; Zivana Milićević; Milica Labudović-Borović; Xiaoping Wang; Martti Laan; Pärt Peterson; Troy D Randall; Jürgen Westermann
Journal:  Histochem Cell Biol       Date:  2011-05-25       Impact factor: 4.304

5.  Alternative NF-κB signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3.

Authors:  Yu Tao; Zhanjie Liu; Yingyong Hou; Shouli Wang; Sanhong Liu; Yuhang Jiang; Dan Tan; Qiulin Ge; Cuifeng Li; Yiming Hu; Zhi Liu; Xi Chen; Qi Wang; Mingliang Wang; Xiaoren Zhang
Journal:  Oncogene       Date:  2018-07-04       Impact factor: 9.867

6.  Comparing the fine specificity of DNA binding by NF-kappaB p50 and p52 using principal coordinates analysis.

Authors:  Anastasia Nijnik; Richard Mott; Dominic P Kwiatkowski; Irina A Udalova
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

7.  A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection.

Authors:  Christian R Engwerda; Manabu Ato; Sara E J Cotterell; Tracey L Mynott; Asiya Tschannerl; Patricia M A Gorak-Stolinska; Paul M Kaye
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers.

Authors:  Giuseppina Bonizzi; Magali Bebien; Dennis C Otero; Kirsten E Johnson-Vroom; Yixue Cao; Don Vu; Anil G Jegga; Bruce J Aronow; Gourisankar Ghosh; Robert C Rickert; Michael Karin
Journal:  EMBO J       Date:  2004-10-07       Impact factor: 11.598

Review 9.  Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification.

Authors:  Karine Breckpot; David Escors
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2009-12       Impact factor: 2.895

10.  The tumor promoter and NF-κB modulator Bcl-3 regulates splenic B cell development.

Authors:  Xiaoren Zhang; Andrea Paun; Estefania Claudio; Hongshan Wang; Ulrich Siebenlist
Journal:  J Immunol       Date:  2013-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.